Cetuximab
Trovati 4 articoli
- Erbitux in combination with Docetaxel and Cisplatin as induction therapy in patients treated for locally advanced head and neck cancer
- Patients treated for locally advanced head and neck cancer may respond better to treatment with the addition of Cetuximab ( Erbitux ) to chemotherapy, according to a phase II study. In the study, 39 patients with stages 3 or 4 head and neck cancer were treated initially with a combination of ... (Leggi Articolo)
- Head and neck tumor: treatment with Cetuximab extends survival
- The FDA ( Food and Drug Administration ) approved Erbitux ( Cetuximab ) for use in combination with radiation therapy to treat patients with squamous cell cancer of the head and neck ( SCCHN ) that can not be removed by surgery. Erbitux, which received a priority review, is the first drug app... (Leggi Articolo)
- Cancer: Cetuximab shows promise
- The results of several clinical studies of Cetuximab ( Erbitux ) have been presented at the American Society of Clinical Oncology ( ASCO ) 41st Annual Meeting. Irinotecan-refractory metastatic colorectal cancer Findings were presented of a randomized Phase II trial conducted by the Natio... (Leggi Articolo)
- Pancreatic cancer: new treatment reduces the size of tumors and lowers the risk of local recurrence of the disease
- A new treatment for pancreatic cancer developed by researchers of Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center substantially reduces the size of tumors and lowers the risk of local recurrence of the disease. Fifty percent of patients in the study responded to therapy -- on... (Leggi Articolo)
